News for Healthier Living

ASCO: HER3-Targeted Antibody-Drug Conjugate (ADC) Shows Promise for Treatment-Resistant Solid Tumors

A new targeted cancer drug, DB-1310, is showing early signs of effectiveness in patients with advanced solid tumors that have not responded to standard treatments, particularly those with EGFR-mutant non-small cell lung cancer.

May 30, 2025


May 31 2025

May 30 2025

May 29 2025

May 28 2025

May 27 2025

May 26 2025

May 25 2025

May 24 2025

May 23 2025

May 22 2025

May 21 2025

May 20 2025

May 19 2025

May 18 2025